Biomarker-guided precision immunotherapy in head and neck cancer: Harnessing toripalimab-tpzi as a PD-1 checkpoint inhibitor

Advances in Biomarker Sciences and Technology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles